BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1798961)

  • 1. The influence of sulfate content and molecular weight of a fucan sulfate from the brown seaweed Ecklonia kurome on its antithrombin activity.
    Nishino T; Aizu Y; Nagumo T
    Thromb Res; 1991 Dec; 64(6):723-31. PubMed ID: 1798961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin activity of a fucan sulfate from the brown seaweed Ecklonia kurome.
    Nishino T; Aizu Y; Nagumo T
    Thromb Res; 1991 Jun; 62(6):765-73. PubMed ID: 1926066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant and antithrombin activities of oversulfated fucans.
    Nishino T; Nagumo T
    Carbohydr Res; 1992 May; 229(2):355-62. PubMed ID: 1394292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sulfate-content dependence of the anticoagulant activity of a fucan sulfate from the brown seaweed Ecklonia kurome.
    Nishino T; Nagumo T
    Carbohydr Res; 1991 Jul; 214(1):193-7. PubMed ID: 1954631
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of the generation of thrombin and factor Xa by a fucoidan from the brown seaweed Ecklonia kurome.
    Nishino T; Fukuda A; Nagumo T; Fujihara M; Kaji E
    Thromb Res; 1999 Oct; 96(1):37-49. PubMed ID: 10554083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization.
    Logeart D; Prigent-Richard S; Jozefonvicz J; Letourneur D
    Eur J Cell Biol; 1997 Dec; 74(4):376-84. PubMed ID: 9438134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin cofactor II-dependent antithrombin activity of calcium spirulan.
    Hayakawa Y; Hayashi T; Hayashi K; Hayashi T; Ozawa T; Niiya K; Sakuragawa N
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):554-60. PubMed ID: 8874866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen inhibits the heparin cofactor II-mediated antithrombin activity of dermatan sulfate.
    Zammit A; Dawes J
    Blood; 1995 Feb; 85(3):720-6. PubMed ID: 7833476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin.
    Bray B; Lane DA; Freyssinet JM; Pejler G; Lindahl U
    Biochem J; 1989 Aug; 262(1):225-32. PubMed ID: 2818566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective cleavage and anticoagulant activity of a sulfated fucan: stereospecific removal of a 2-sulfate ester from the polysaccharide by mild acid hydrolysis, preparation of oligosaccharides, and heparin cofactor II-dependent anticoagulant activity.
    Pomin VH; Pereira MS; Valente AP; Tollefsen DM; Pavão MS; Mourão PA
    Glycobiology; 2005 Apr; 15(4):369-81. PubMed ID: 15590773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. II. Degradation and molecular weight effect.
    Logeart D; Prigent-Richard S; Boisson-Vidal C; Chaubet F; Durand P; Jozefonvicz J; Letourneur D
    Eur J Cell Biol; 1997 Dec; 74(4):385-90. PubMed ID: 9438135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant properties of a fucoïdan fraction.
    Colliec S; Fischer AM; Tapon-Bretaudiere J; Boisson C; Durand P; Jozefonvicz J
    Thromb Res; 1991 Oct; 64(2):143-54. PubMed ID: 1811335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation, purification, and characterization of fucose-containing sulfated polysaccharides from the brown seaweed Ecklonia kurome and their blood-anticoagulant activities.
    Nishino T; Yokoyama G; Dobashi K; Fujihara M; Nagumo T
    Carbohydr Res; 1989 Feb; 186(1):119-29. PubMed ID: 2720702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural characterization of a new anticoagulant fucan sulfate from the brown seaweed Ecklonia kurome.
    Nishino T; Nagumo T; Kiyohara H; Yamada H
    Carbohydr Res; 1991 Apr; 211(1):77-90. PubMed ID: 1773433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of potentiation of antithrombin III and heparin cofactor II inhibition by sulfated xylans.
    Carson L; Doctor VM
    Thromb Res; 1990 May; 58(4):367-81. PubMed ID: 1972302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acetylthrombin on protein C activation and fibrinogen clotting.
    Nakagomi K; Ajisaka K; Yokota I
    Thromb Res; 1990 Aug; 59(4):713-22. PubMed ID: 1964250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin cofactor II is degraded by heparan sulfate and dextran sulfate.
    Saito A
    Biochem Biophys Res Commun; 2015 Feb; 457(4):585-8. PubMed ID: 25600805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of thrombin by a fucosylated chondroitin sulfate from echinoderm.
    Mourão PA; Boisson-Vidal C; Tapon-Bretaudière J; Drouet B; Bros A; Fischer A
    Thromb Res; 2001 Apr; 102(2):167-76. PubMed ID: 11323028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin inhibitory activity of heparin cofactor II depends on the molecular weight and sulfate amount of dextran sulfate.
    Yamagishi R; Niwa M; Sakuragawa N
    Thromb Res; 1986 Nov; 44(3):347-54. PubMed ID: 2432675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity chromatography of sulphated polysaccharides separately fractionated on antithrombin III and heparin cofactor II immobilized on concanavalin A--sepharose.
    Sinniger V; Tapon-Bretaudière J; Millien C; Muller D; Jozefonvicz J; Fischer AM
    J Chromatogr; 1993 Jun; 615(2):215-23. PubMed ID: 8335699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.